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Abstract
Background: Iron fortification of  foods is currently a strategy employed to fight iron deficiency in countries. Liposomes were 
assumed to be a potential carrier of  iron supplements.
Objective: The objective of  this study was to investigate the iron transport from ferrous glycinate liposomes, and to estimate 
the effects of  liposomal carriers, phytic acid, zinc and particle size on iron transport using Caco-2 cell models.
Methods: Caco-2 cells were cultured and seeded in DMEM medium. Minimum essential medium was added to the basolateral 
side. Iron liposome suspensions were added to the apical side of  the transwell.
Results: The iron transport from ferrous glycinate liposomes was significantly higher than that from ferrous glycinate. In the 
presence of  phytic acid or zinc ion, iron transport from ferrous glycinate liposomes and ferrous glycinate was evidently inhibited, 
and iron transport decreased with increasing phytic acid concentration. Iron transport was decreased with increase of  particle 
size increasing of  ferrous glycinate liposome.
Conclusion: Liposomes could behave as more than a simple carrier, and iron transport from liposomes could be implemented 
via a mechanism different from the regulated non-heme iron pathway.
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Introduction
Iron deficiency is a common nutritional disorder problem 
worldwide1. Insufficient dietary intake and low iron bio-
availability in foods are usually the primary contributing 
causes of  iron deficiency2,3. Iron fortification of  foods 
is currently a strategy employed to fight iron deficiency 
in countries4. Iron supplements utilized in food fortifica-
tion should be readily bioavailable, stable and safe5. Lipo-
somes are  potential carriers6,7, and the delivery systems 
have been used to increase iron absorption in certain 
food matrices such as dairy products8.
Most of  traditional iron supplements could injure the 
mucosa of  the gastrointestinal tract, and high iron intake 
could also lead to iron overload in some human being, 
which could result in cell toxicity and side effects such 
as respiratory morbidities, nausea, abdominal discomfort, 
constipation, and an increased risk of  infection. Com-
pared with common iron supplements, iron liposomes 
can obviously increase the iron levels and haemoglobin 
concentrations in serum so as to alleviate the anemia9,10. 
Liposomal iron did not aggravate the oxidative stress at 
the same time of  increasing iron levels in serum. More-
over, iron liposomes are microvesicles and mostly nano-
sized particles, they also have physical stability and grad-
ual release properties. Furthermore, they have no toxicity 
and minimal side effects to the body than unencapsulated 
iron supplements7,8.
The absorption of  non-heme iron, such as ferrous sul-
phate, could be restrained by several factors. Phytic acid 
in diets based on cereals and legumes has been shown 
to inhibit iron absorption in humans and in cell culture 
models11. It has also been proved that some divalent met-
al ions (such as Zn2+) decreased iron uptake12. The core 
material bioavailability could be improved by liposomes8, 
and the delivery efficiencies of  liposomes to core mate-
rials are significantly influenced by liposomal physico-
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chemical properties, such as particle size13. However, the 
effects of  these factors on the regulation of  iron trans-
port by liposomes are still obscure.
The Caco-2 cells, a human adenocarcinoma cell line, 
shows promise as a rapid and low-cost model to predict 
iron absorption from foods and iron fortificants14,15. The 
model system has been applied numerously to estimate 
relative iron bioavailability from varieties of  staple food 
crops, commercial food products, and meals or specif-
ic food, etc15,16. To further assess the regulation of  lipo-
somes, iron transport experiments with ferrous glycinate 
liposomes were performed using Caco-2 cell model.
Ferrous glycinate as an iron chelate has been microen-
capsulated using liposomes in previous work, and the pH 
stability of  the iron supplement obviously increased17, 18. 
The objective of  the present study was to evaluate the 
regulation of  iron transport by liposomes using Caco-2 
cell model, and to provide information on the effects of  
known inhibitors of  iron transport from ferrous glycinate 
liposomes (i.e. phytic acid and zinc), and to determine 
the effects of  liposome particle size. Documentation of  
these results will be valuable to understand the regulation 
of  liposomes on iron transport and to predict the iron 




Egg phosphatidylcholine (EPC), cholesterol, Tween 
80 and diethyl ether were purchased from Sinopharm 
Chemical Reagent Co., Ltd (Shanghai, China). Minimum 
essential medium (MEM medium), D-Hanks buffer, 
phytic acid and ZnCl2 were obtained from Sigma-Aldrich 
Co., LLC (Shanghai, China). All chemicals were of  re-
agent grade and used without further purification. Fer-
rous glycinate was synthesized according to CN Patent 
ZL200410065260.3.
Preparation of  ferrous glycinate liposomes
Ferrous glycinate liposomes were prepared by reverse 
phase evaporation (REV) method19. Briefly, the lip-
id mixture, containing EPC (200 mg) and cholesterol 
(20 mg), was dissolved in 10 mL diethyl ether (organic 
phase). Ferrous glycinate (40 mg) was dissolved in 3 mL 
aqueous solution (phosphate buffer solution, PBS, 0.05 
mol/L, pH6.8). The aqueous phase was added to the 
organic phase, and then a homogeneous w/o emulsion 
was obtained by ultrasonication with a probe sonicator 
(VCX400, Sonics & Material, USA) with a sequence of  1 
s on and 1 s off  (sonication power 300 W) in an ice bath 
for 5 min. The w/o emulsion in a round bottom flask was 
evaporated using a rotary evaporator under reduced pres-
sure at 40oC, and a gel was formed. Upon further rotary 
evaporation, the gel was broken, and then 10 mL PBS 
buffer (0.05 mol/L, pH6.8) containing 100 mg Tween 80 
was added with gentle vortexing and the sample was se-
quentially evaporated for 30 min at 40oC. The residual 
diethyl ether was evacuated by nitrogen gas.
Procedures to purify ferrous glycinate liposomes and 
to control liposomal particle sizes
The purification and particle size control of  ferrous gly-
cinate liposomes was processed simultaneously. Firstly, 
liposomes were separated according to the particle size 
by Sephadex G-100 column (20 cm × 1 cm id), and the 
samples were eluted using 0.9% (w/v) NaCl solution, and 
the eluate was collected by test tubes per minute. Second-
ly, liposomes were extruded to adjust particle sizes using 
an ultrafiltration cell (Amicon stirred cell 8010, Millipore, 
USA) with a polycarbonate membrane (1.0, 0.6, 0.4, 0.2, 
and 0.1 μm pores). Samples were extruded through a 
membrane using N2 gas, and extruded solution was col-
lected. The obtained solution could be further extruded 
to reduce the particle size using a membrane with next 
smaller pore size. At last, the first step was repeated to 
eliminate free iron. Particle size and size distribution were 
measured by dynamic light scattering with a ZEN3600 
Zetasizer nano instrument (Malvern Instrument, Worcs, 
UK).
Cell culture
Caco-2 cells were obtained from the American Type Cul-
ture Collection (Rockville, MD, USA) between passag-
es 25 to 30. Cells were cultured in DMEM medium for 
14 d, 10% fetal bovine serum (FBS), 4.5 g/L glucose, 2 
mmol/L L-glutamine, 100 U/mL penicillin and 100 U/
mL streptomycin; the medium was replaced every two 
day. Caco-2 cells were seeded in flasks and incubated 
at 37 oC, under a 5% CO2 in air atmosphere. After one 
week, the cells were harvested and reseeded in 12-well 
transwell plates at a density of  5×104 cells/cm
2, and incu-
bated to reach 100% confluence at 37oC, under a 5% CO2 
in air atmosphere. Transepithelial electrical resistance 
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(TEER) was measured to check the integrity of  Caco-2 
cell monolayers. The transwells consisted of  the apical 
chamber (which simulated the intestinal lumen) and the 
basal chamber (which would collect the bioavailable iron), 
which were separated by a polycarbonate membrane with 
0.4 μm pores.
Iron transport in Caco-2 cells
The apical and basolateral surfaces of  Caco-2 cells in the 
transwell were rinsed three times with D-Hanks buffer 
solution. Then, 500 μl of  MEM medium (contained no 
added iron), previously warmed at 37oC, was added to the 
basolateral side. Iron transport was started by the addi-
tion of  300 μl (1, 10, 20 and 50 μmol/L iron, containing 
predetermine amount of  phytic acid or ZnCl2 ) of  iron li-
posomes or ferrous glycinate in D-Hanks buffer solution 
in the apical side of  the transwell. Then, they were incu-
bated for 120 min at 37oC, under 5% CO2. After incuba-
tion, the transport was stopped by washing the inserts 
three times with ice-cold 1 mmol/L EDTA in PBS buffer 
(0.01 mol/L, pH7.4). The basolateral side solution was 
recovered for the determination of  the iron transported 
across Caco-2 cells.
Determination of  iron
The iron concentration was measured according to the 
procedure described by Jorhem20. Briefly, aliquots of  the 
samples were disrupted to remove organic compounds 
and to release elemental iron thoroughly by ashing for 
10 h at 450oC in a muffle furnace. The inorganic residues 
were dissolved in 1 mol/L HCl. The determination of  
iron was performed by graphite furnace atomic absorp-
tion spectrophotometry (AAS, Zeenit 700P, Analytik Jena 
AG, Germany) at 248.3 nm. The calibration curves were 
performed with standard solutions containing 0-6 μg/mL 
of  ferric chloride in 1% (V/V) nitric acid.
Data analysis and statistical evaluation
The iron transport was calculated based on the iron 
amount as determined by AAS and the surface area of  
the cell monolayer. The iron transport was calculated us-
ing the following equation:
Iron transport (pmol/cm2)= MAFe/A
where MAFe is the amount of  substance of  iron in the ba-
solateral side; A is the surface area of  the cell monolayer.
Statistical analysis of  the data was performed using Mat-
lab software (Version 7.11.0.584(R2010b), MathWorks, 
Inc. Natick,Massachusetts, USA). Differences in the 
amount of  iron transport were compared using two-way 
ANOVA. The differences were considered significantly 
different if  P values were less than or equal to 0.05. Vari-




Effect of  incubation time on iron transport from fer-
rous glycinate liposomes
Iron transport across Caco-2 cells treated with increasing 
incubation time at four levels, 30, 60, 90, and 120 min, are 
shown in Figure 1. Iron transport of  ferrous glycinate li-
posomes was in agreement with that of  ferrous glycinate, 
which was time-dependent for the period of  120 min, 
and the iron tended to increase with increasing incuba-
tion time. Moreover, iron transport was increased with 
increasing of  iron concentrations. The iron transport 
from ferrous glycinate liposomes was significantly higher 
than that from ferrous glycinate (two-way ANOVA; incu-
bation time and iron sources, F[1, 16]=9.38, p=0.0074). 
Compared to ferrous glycinate, the relative iron transport 
of  ferrous glycinate liposomes at 1, 10, and 50 μmol/L 
and incubation for 120 min were 146.1%, 131.1%, and 
128.9%, respectively, which indicated that the iron of  
ferrous glycinate liposomes across Caco-2 cells could be 
more efficient.
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Figure 1: Effects of  incubation time on iron transport across Caco-2 cells. Ferrous glycinate liposomes and 
ferrous glycinate are expressed in solid lineseries and dashed line series, respectively. Values are means ± SD, n = 3.
Ferrous glycinate liposomes demonstrated higher iron 
transport than that from ferrous glycinate at the same 
iron level. The difference in the values of  iron transport 
between the two iron sources was not so apparently in 
the initial phase or at low iron concentration, whereas the 
iron transport from ferrous glycinate liposomes was obvi-
ous higher than that from ferrous glycinate at the ultimate 
stage and at high concentration. The higher iron trans-
port of  ferrous glycinate liposomes could result from the 
protection of  ferrous glycinate by liposomal vesicles18. 
The lipophile of  liposomes was higher than that of  fer-
rous glycinate, so the affinity between ferrous glycinate 
and cells could be enhanced by the iron encapsulated in 
liposomes21,22. In addition, particle sizes of  ferrous glyci-
nate liposomes were nano-scale, so the liposomes could 
behave in nanoparticle effects23.
Effects of  phytic acid on iron transport from ferrous 
glycinate liposomes
Iron bioavailability was decreased by many inhibitors in 
the daily diet. Phytic acid extensively exists in vegetable 
food, such as cereals, beans, and it is a strong inhibitor 
of  non-heme iron transport24,25. Figure 2 documented the 
iron transport in response to increasing concentrations 
of  phytic acid. In the presence of  phytic acid, iron trans-
port from ferrous glycinate liposomes and ferrous glyci-
nate was evidently inhibited, and iron transport decreased 
with increasing of  phytic acid concentration. However, 
two-way ANOVA results (phytic acid concentration and 
iron sources, F[1, 20]=575.15, p<0.001) showed that ef-
fects of  phytic acid on iron transport from ferrous gly-
cinate liposomes and ferrous glycinate were significantly 
different. Compared with ferrous glycinate, iron transport 
from ferrous glycinate liposomes was less inhibited by 
phytic acid. For example, at the iron concentration of  50 
μmol/L, the iron transport at phytic acid concentration 
of  100, 200, 500, and 1000 μmol/L were decreased by 
3.0%, 4.6%, 7.4%, and 14.0% for ferrous glycinate lipo-
somes and by 8.0%, 16.5%, 27.0%, and 45.2% for ferrous 
glycinate, respectively. Compared to ferrous glycinate, the 
relative iron transport of  ferrous glycinate liposomes at 
1, 10, 20, and 50 μmol/L at phytic acid concentration of  
100 μmol/L were 213.7%, 149.4%, 136.2%, and 135.9%, 
respectively.
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Figure 2: Effects of  phytic acid on iron transport across Caco-2 cells. Ferrous glycinate liposomes and ferrous 
glycinate are expressed in solid line series and dashed line series, respectively. Values are means ± SD, n = 3.
Phytic acid has proved to be a stubborn inhibitor of  iron 
absorption in humans, which widely exists in cereals and 
soybeans11,26. The compound is prone to chelate divalent 
metal ions and to form insoluble and indigestible chelate 
complex, which would result in the loss of  iron absorp-
tion27. The results of  Figure 2 exhibited that iron trans-
port from ferrous glycinate was seriously decreased by 
phytic acid. However, iron transport from ferrous glyci-
nate liposomes was less inhibited by the organic acid. The 
higher iron transport from ferrous glycinate liposomes 
may be due to the encapsulation of  ferrous glycinate in 
liposomes, and the iron was protected from phytic acid 
by the phospholipids bilayer membrane, which prevented 
the formation of  insoluble phytate-iron complex28.
Effects of  Zinc ion on iron transport from ferrous 
glycinate liposomes
The interactions of  iron and zinc in foods represent crit-
ical nutrition issues. The effects of  zinc on iron transport 
are summarized in Figure 3. The addition of  zinc at con-
centrations of  0, 10, 50, 100, and 300 μmol/L decreased 
iron transport, which was decreased with increasing of  
zinc concentration. However, judging from the two-way 
ANOVA results (ZnCl2 concentration and iron sources, 
F[1, 20]=448.64, p<0.001), there were significantly differ-
ent effects of  ZnCl2 on iron transport from ferrous gly-
cinate liposomes and ferrous glycinate. Compared with 
ferrous glycinate, iron transport from ferrous glycinate 
liposomes was less affected by zinc. For instance, at the 
iron concentration of  50 μmol/L, iron transport at zinc 
concentration of  10, 50, 100 and 300 μmol/L were de-
creased by 4.7%, 9.6%, 14.1%, and 20.9% for ferrous gly-
cinate liposomes and by 9.7%, 28.7%, 48.0%, and 57.2% 
for ferrous glycinate, respectively. Compared to ferrous 
glycinate, the relative iron transport of  ferrous glycinate 
liposomes at 1, 10, 20, and 50 μmol/L at the zinc con-
centration of  50 μmol/L were about 10.3-fold, 2.0-fold, 
2.2-fold, and 1.6-fold, respectively. The results implied 
that liposomes could improve the anti-inhibition of  iron.
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Figure 3: Effects of  ZnCl2 on iron transport across Caco-2 cells. Ferrous glycinate liposomes and ferrous glycinate 
are expressed in solid line series and dashed line series, respectively. Values are means ± SD, n = 3.
Plenty of  literature evidenced that the interaction of  iron 
and zinc in foods was antagonistic effect, which would 
cause the reduction in bioavailability of  the two mineral 
elements29,30. Espinoza et al. and Iyengar et al. reported 
that divalent metal transporter 1 (DMT1) and/or Zip14 
(Zrt- and Irt-like protein 14) were the probable iron and 
zinc interaction site31,32. Representative results from Fig-
ure 3 indicated that iron transport from ferrous glycinate 
was sharply decreased with increasing of  zinc concentra-
tion. It could be inferred that the antagonism between 
iron and zinc has not been eliminated. Compared to fer-
rous glycinate, the higher iron transport from ferrous gly-
cinate liposomes might be attributed to the fact that the 
iron was encapsulated in liposomal vesicles. Liposomes 
could be delivered via membrane fusion, diffusion or 
phagocytosis33,34, so iron was more efficiently transport-
ed. It could be speculated that ferrous glycinate loaded 
in phospholipid vesicles could be transported by lipo-
somes rather than DMT1 protein. It was conceivable that 
ferrous glycinate liposomes could be absorbed through 
endocytic pathway, and the antagonistic effect between 
iron and zinc was abated. Pereira et al. affirmed that iron 
encapsulated in nanoparticles was utilized following ac-
quisition by endocytic uptake35. Niu et al. reported that 
liposomes were likely to be absorbed intact via the M-cell 
or the epithelia pathways13. However, the bilayer mem-
brane of  liposomes could be destroyed by divalent met-
al cation-induced destabilization36. And it could lead to 
leakage of  iron from ferrous glycinate liposomes, and the 
iron transport decreased.
Effect of  particle size on iron transport from ferrous 
glycinate liposomes
Iron transport of  ferrous glycinate liposomes at five parti-
cle sizes, 70, 100, 150, 300, and 500 nm were assessed (Fig-
ure 4). As shown in Figure 4, iron transport was decreased 
with particle size increasing of  ferrous glycinate liposome 
at selected iron concentrations. A two-way ANOVA was 
performed to determine the statistical significance of  par-
ticle size and iron concentration as factors. Significant ef-
fects of  particle size and the interaction between particle 
size and iron concentration interactions were observed ( 
one-way ANOVA, particle size, F[4, 40]=84.94, p<0.001; 
two-way ANOVA, particle size and iron concentration, 
F[12, 40]=4.81, p<0.001). liposomes with smaller parti-
cle size of  about 70 nm exhibited evidently higher iron 
transport than liposomes with bigger particle size of  300 
and 500 nm (two-way ANOVA; p<0.001 in both cases). 
Liposomes with particle size of  300 and 500 nm exhibit-
ed lower iron transport. The iron transport was not sig-
African Health Sciences Vol 17 Issue 3, September, 2017938
nificantly different (p>0.05) between these two particle 
sizes. An example of  the effects of  particle sizes was the 
decrease of  the iron transport with particle size increas-
ing at the iron concentration of  50 μmol/L (ANOVA; 
F[4, 10]=29.91; p<0.001), and compared to that of  70 
nm the iron transport was decreased by 11.4%, 20.1%, 
26.9%, 33.3% for ferrous glycinate liposomes with parti-
cle sizes of  100, 150, 300, and 500 nm, respectively. The 
obvious size-dependent behavior indicated some kind of  
size-dependent recognition and internalization of  ferrous 
glycinate liposomes.
Figure 4: Effects of  mean particle size on iron transport across Caco-2 cells. Values are means ± SD, n = 3.
It has been revealed that particle size plays a vital role in 
nanoparticle adhesion to and interaction with biological 
cells37,38. Iron transport from ferrous glycinate liposomes 
was size-dependent, i.e. it increased with the decreasing 
of  particle sizes (Figure 4). In the present study, these re-
sults were coincident with previous results in which core 
material bioavailability from liposomes increased with 
particle size decreasing37,39. It was generally supposed that 
particles within the 100-200 nm size range could be in-
ternalized via the pathway of  receptor-mediate endocy-
tosis, while particles with larger sizes would be captured 
by phagocytosis37. However, particles in the size range 
of  approximately 2-100 nm could play an active role in 
mediating biological effects more than being carriers. Sig-
naling processes essential for basic cell functions could 
be altered by the smaller particles39. The exact absorption 
mechanisms of  particles with different sizes need to be 
elucidated in further studies.
The iron transport offered as ferrous glycinate liposomes 
was evaluated using Caco-2 cells, as a model of  human 
intestinal epithelia. The results from this study strongly 
suggest that iron from ferrous glycinate liposomes was 
transported more effectively than that from ferrous gly-
cinate. The effects of  some common inhibitors, such as 
phytic acid and zinc on, on iron transport from liposomes 
were obviously decreased, compared to ferrous glycinate. 
It may be ascribed to the protection of  phospholipide 
bilayer membrane on ferrous glycinate from common in-
hibitors. The fact quite possibly meant that the transport 
pathway of  iron encapsulated in liposomes was different 
from that of  free-iron. Furthermore, the iron transport 
was regulated by the size of  liposomes, and it decreased 
with particle size increasing. Liposomes with the sizes of  
less than 100 nm, among 100-200 nm, and larger than 
200 nm could be taken up via different pathways, such as 
altering signaling processes essential for basic cell func-
tions, receptor-mediate endocytosis, phagocytosis, rather 
than traditional absorption pathway.
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Conclusion
Liposomes could behave as more than a simple carrier, 
and iron transport from liposomes could be implemented 
via a mechanism different from the regulated non-heme 
iron pathway.
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